Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 52

References for PMC Articles for PubMed (Select 22706385)

1.

Phospholipid transfer activity of microsomal triglyceride transfer protein produces apolipoprotein B and reduces hepatosteatosis while maintaining low plasma lipids in mice.

Khatun I, Zeissig S, Iqbal J, Wang M, Curiel D, Shelness GS, Blumberg RS, Hussain MM.

Hepatology. 2012 May;55(5):1356-68. doi: 10.1002/hep.25504. Epub 2012 Mar 20.

2.

Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection.

Brigl M, Tatituri RV, Watts GF, Bhowruth V, Leadbetter EA, Barton N, Cohen NR, Hsu FF, Besra GS, Brenner MB.

J Exp Med. 2011 Jun 6;208(6):1163-77. doi: 10.1084/jem.20102555. Epub 2011 May 9.

3.

IL-21 is pivotal in determining age-dependent effectiveness of immune responses in a mouse model of human hepatitis B.

Publicover J, Goodsell A, Nishimura S, Vilarinho S, Wang ZE, Avanesyan L, Spolski R, Leonard WJ, Cooper S, Baron JL.

J Clin Invest. 2011 Mar;121(3):1154-62. doi: 10.1172/JCI44198.

4.

Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.

Zeissig S, Dougan SK, Barral DC, Junker Y, Chen Z, Kaser A, Ho M, Mandel H, McIntyre A, Kennedy SM, Painter GF, Veerapen N, Besra GS, Cerundolo V, Yue S, Beladi S, Behar SM, Chen X, Gumperz JE, Breckpot K, Raper A, Baer A, Exley MA, Hegele RA, Cuchel M, Rader DJ, Davidson NO, Blumberg RS.

J Clin Invest. 2010 Aug;120(8):2889-99. doi: 10.1172/JCI42703. Epub 2010 Jul 1.

5.

Sequential control of hepatitis B virus in a mouse model of acute, self-resolving hepatitis B.

von Freyend MJ, Untergasser A, Arzberger S, Oberwinkler H, Drebber U, Schirmacher P, Protzer U.

J Viral Hepat. 2011 Mar;18(3):216-26. doi: 10.1111/j.1365-2893.2010.01302.x.

PMID:
20367794
6.
7.

Recognition of lyso-phospholipids by human natural killer T lymphocytes.

Fox LM, Cox DG, Lockridge JL, Wang X, Chen X, Scharf L, Trott DL, Ndonye RM, Veerapen N, Besra GS, Howell AR, Cook ME, Adams EJ, Hildebrand WH, Gumperz JE.

PLoS Biol. 2009 Oct;7(10):e1000228. doi: 10.1371/journal.pbio.1000228. Epub 2009 Oct 27.

8.

Determination of cellular lipids bound to human CD1d molecules.

Cox D, Fox L, Tian R, Bardet W, Skaley M, Mojsilovic D, Gumperz J, Hildebrand W.

PLoS One. 2009;4(5):e5325. doi: 10.1371/journal.pone.0005325. Epub 2009 May 5.

9.

Early kinetics of innate and adaptive immune responses during hepatitis B virus infection.

Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A, Orlandini A, Sacchelli L, Missale G, Ferrari C.

Gut. 2009 Jul;58(7):974-82. doi: 10.1136/gut.2008.163600. Epub 2009 Feb 6.

PMID:
19201769
10.

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

Yeo W, Chan TC, Leung NW, Lam WY, Mo FK, Chu MT, Chan HL, Hui EP, Lei KI, Mok TS, Chan PK.

J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.

11.

Microsomal triglyceride transfer protein regulates endogenous and exogenous antigen presentation by group 1 CD1 molecules.

Kaser A, Hava DL, Dougan SK, Chen Z, Zeissig S, Brenner MB, Blumberg RS.

Eur J Immunol. 2008 Aug;38(8):2351-9. doi: 10.1002/eji.200738102.

12.

Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus.

Guy CS, Mulrooney-Cousins PM, Churchill ND, Michalak TI.

J Virol. 2008 Sep;82(17):8579-91. doi: 10.1128/JVI.01022-08. Epub 2008 Jul 2.

13.

Regulation of energy substrate utilization and hepatic insulin sensitivity by phosphatidylcholine transfer protein/StarD2.

Scapa EF, Pocai A, Wu MK, Gutierrez-Juarez R, Glenz L, Kanno K, Li H, Biddinger S, Jelicks LA, Rossetti L, Cohen DE.

FASEB J. 2008 Jul;22(7):2579-90. doi: 10.1096/fj.07-105395. Epub 2008 Mar 17.

14.

Immunobiology and pathogenesis of viral hepatitis.

Guidotti LG, Chisari FV.

Annu Rev Pathol. 2006;1:23-61. Review.

PMID:
18039107
15.

Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.

Vilarinho S, Ogasawara K, Nishimura S, Lanier LL, Baron JL.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18187-92. Epub 2007 Nov 8.

16.

The unique role of natural killer T cells in the response to microorganisms.

Tupin E, Kinjo Y, Kronenberg M.

Nat Rev Microbiol. 2007 Jun;5(6):405-17. Epub 2007 May 8. Review.

PMID:
17487145
17.

Invariant NKT cells amplify the innate immune response to lipopolysaccharide.

Nagarajan NA, Kronenberg M.

J Immunol. 2007 Mar 1;178(5):2706-13.

18.

MTP regulated by an alternate promoter is essential for NKT cell development.

Dougan SK, Rava P, Hussain MM, Blumberg RS.

J Exp Med. 2007 Mar 19;204(3):533-45. Epub 2007 Feb 20.

19.

The biology of NKT cells.

Bendelac A, Savage PB, Teyton L.

Annu Rev Immunol. 2007;25:297-336. Review.

PMID:
17150027
20.

Hepatitis B virus (HBV) reactivation with immunosuppressive therapy in rheumatic diseases: assessment and preventive strategies.

Calabrese LH, Zein NN, Vassilopoulos D.

Ann Rheum Dis. 2006 Aug;65(8):983-9. Epub 2006 Apr 20. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk